Pfizer PFE Pfizer CentreOne — Revenues:
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's pfizer centreone — revenues:.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pfizer's pfizer centreone — revenues:?
- Pfizer (PFE) reported pfizer centreone — revenues: of $289M in Q1 2026.
- How has Pfizer's pfizer centreone — revenues: changed year-over-year?
- Pfizer's pfizer centreone — revenues: increased by 5.9% year-over-year, from $273M to $289M.
- What is the long-term trend for Pfizer's pfizer centreone — revenues:?
- Over 4 years (2021 to 2025), Pfizer's pfizer centreone — revenues: has grown at a -6.0% compound annual growth rate (CAGR), from $1.73B to $1.35B.
- What does pfizer centreone — revenues: mean?
- Total revenue earned from providing contract manufacturing and development services to other pharmaceutical companies.
- How do you interpret pfizer centreone — revenues:?
- An increase suggests successful expansion of the CDMO service business and higher utilization of manufacturing assets, while a decrease may indicate reduced demand for outsourced manufacturing or increased competition in the CDMO market.
- How does pfizer centreone — revenues: compare across companies?
- Comparable to CDMO revenue streams reported by other large pharmaceutical companies with internal manufacturing service divisions or independent CDMO firms like Lonza or Catalent.